Skip navigation

Boston Scientific shares jump on strong 2Q results

Shares of Boston Scientific Corp. jumped Thursday after the medical device maker reported better-than-expected earnings from sales of its stents and other cardiovascular devices. Full story

Abbott will pay $560M to acquire 2 med tech firms

Abbott Laboratories announced Monday it would pay a combined $560 million to acquire two privately-held companies focused on coronary implants and laser-assisted eye surgery. Full story

Sales reps' presence tied to heart stent use: study

NEW YORK (Reuters Health) - Having sales representatives from medical device companies at hospitals may influence which products doctors use and ultimately drive up costs, according to a new study from Canada. Full story

Heart bypass surgery or stents? Depends on patient

NEW YORK (Reuters Health) - The average person with multiple diseased arteries in the heart does slightly better following coronary artery bypass surgery than after having stents inserted, a new study suggests, but the optimal procedure varies by patient. Full story

Court reverses $482 million stent case against Cordis

WASHINGTON (Reuters) - Cordis Corp, a Johnson and Johnson <JNJ.N> subsidiary, did not infringe on a patent owned by a radiologist in making its Cypher stents, an appeals court said on Thursday, reversing a ruling by a lower court that ordered Cordis to pay $482 million. Full story

New hope for glaucoma patients

   Revolutionary stents relieve pressure on the eye. KARE's Renee Tessman reports.

Sponsored Links

Articles

Heart stent with new polymer matches Abbott top seller in study

Self-expanding stent shows benefit in study: Stentys

Lombard Medical Tech wins U.S. nod for aortic stent

FDA restricts use of Stryker brain stent

advertisement | ad info